Markers of impaired growth of pulmonary function in children and adolescents

C S Ulrik1, V Backer

  • 1Department of Clinical Physiology and Nuclear Medicine KF, Rigshospitalet, and Department of Internal Medicine I, Pulmonary Unit, Bispebjerg Hospital, Copenhagen, Denmark.

Insights

Asthma, airway hyperresponsiveness, and house dust mite (HDM) allergy negatively impact lung function growth in children. Even without asthma, HDM sensitization impairs FEV1 growth, highlighting allergy

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Pulmonary function growth in children is not fully understood.
  • Factors influencing lung function development require further investigation.

Purpose of the Study:

  • To investigate the relationship between various factors and pulmonary function growth in children and adolescents.
  • To identify predictors of lung function trajectories in pediatric populations.

Main Methods:

  • Longitudinal study of 408 children (7-17 years) over 6 years.
  • Assessment of pulmonary function (FEV1), allergen reactivity, and airway responsiveness (AR).
  • Definition of airway hyperresponsiveness (AHR) based on histamine challenge.

Main Results:

  • Asthma, atopy to house dust mite (HDM), and increasing AR were linked to lower FEV1 %pred cross-sectionally.
  • Longitudinally, asthma and lower baseline FEV1 predicted reduced FEV1 at follow-up.
  • Increased AR, new asthma, and new HDM atopy predicted lower FEV1, even in non-asthmatic subjects without AHR.

Conclusions:

  • Pulmonary function growth in children is negatively affected by asthma, increasing airway responsiveness, and HDM atopy.
  • HDM sensitization impacts FEV1 growth, irrespective of asthma or AHR status.
  • Early identification and management of HDM allergy may be crucial for optimal lung development.

Related Concept Videos

Physical Assessment of the Respiratory Tract II: Inspection01:27

Physical Assessment of the Respiratory Tract II: Inspection

Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration can...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...